Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
Attempted a feeble rally this morning which has fizzled out. Normal service resumed.
I know some are getting itchy fingers thinking this looks cheap now. A few have jumped in - too early imo.
Remember the current narrative in the market is cash. And all the while that remains unresolved this will not rally. So imo keep your powder dry. This is quite possibly going to 11p.
FlyingF - I think a take out valuation of £25-30m is most likely. This would give a handsome return on the current sub £6m (crazy) valuation.
Whether the take out comes in the short term or not (don’t forget we have a ‘Trojan Horse’ on the board now ;)) I think the shares have bottomed out. Sales are now accelerating across all sectors. The company has pledged to be more sharply commercially focused. They will be with the new NED who, incidentally, I think will be appointed the new CEO as his credentials are impeccable. Plus he will likely facilitate a takeover.
Surely this is a positive indicator for ITM if BP see this as the future….
https://www.chemanalyst.com/NewsAndDeals/NewsDetails/bp-ventures-into-green-hydrogen-production-in-a-strategic-move-24677
MC £5.89m for this company. Crazy. OK I know it’s progressed at a snails pace for years now.
However I think this is finally at an inflection point. The company operates in a number of industrial sectors covering a variety of different requirements.
Their product is top notch. Best in class. HCP is being banned later this year and Hardide have THE best replacement - USP.
Sales and contracts are only going to grow from hereonin. Here lies the rub. They have limited reactor capacity to meet future demand. They will need to scale up but do not have the resources. They are ok for now as regards capacity but longer term they will need more factories, more reactors.
There is only one viable solution - being taken out. They are so vulnerable to take over now because potential suitors can see they are on an upward sales growth across all sectors. The company is ridiculously cheap. A takeover would work excellently for Hardide and would be great value and a superb acquisition for one of a host of companies.
At this level it’s an absolute screaming buy but DYOR
Wiseys- ahhh a tamper fight back very good. And you are correct of course, it does take time I don’t think anybody is disputing that, so you’re somewhat missing the point if I may say so.
Incidentally where on earth did you get 2 1/2 thousand per month sale target from? I’ve not seem that quoted anywhere? When questioned about sales targets the other day Jon Burrows solemnly declared it would be remiss and irresponsible of him at this stage to start talking about, sales targets.
And as for institutional investors, rubbing their hands with glee, they will have plenty of opportunity to pick up lots of stock in the impending fundraising. ;)
The other day I checked out the NHS Lanarkshire page on LinkedIn and, would you believe, they were advertising for a eHealth Digital Transformation Project Manager. Just coincidental given the current WhatsApp issue and the imminent need to report back to the ICO? Obviously there could and will be a number of projects in this area but I guess we’ll find out soon enough. I was going to post the link but I looked again and couldn’t find it. I don’t pay so maybe I’d used up my searches.
And wouldn’t you have thought they would be onto all these things long ago. Market due diligence on the CIRT Test before commercialisation. How will the market react? The people who we want to sell to?
With the PSE Test and the large trial why are they reacting so belatedly?
Was it arrogance? Complacency? Naivety?
In all my years of investing on AIM I’ve seen a lot of c*ck ups. But what I’ve never seen is an act of such self destruction by a BOD, specifically Burrows in less than 24 hours!
He has gone from Hero to Zero in very short order. And, frankly, I’m feeling pretty stupid that I trusted him.
Wow Dug that’s an expansive BOD LOL. I think there’s some Big Pharma that don’t have such a large array of management! Not hard to see where all that shareholder cash is going.
This lot totally believe in putting the Cart firmly before the Horse.
OK the 25k trade 4.05p is my buy. Yes I know it’s a pure binary punt. £1k which I can write off if necessary but the upside (if it were to happen) fwiw is worth the risk imo.
I know the bear points - ie.administration quite possible
The bull points:
Iain Ross - track record in industry redx Pharma etc
Biotech sector showing signs of life?
So much R&D here - all goes to waste?
Praised by unnamed Pharma industry partner
Exosome sector due to grow substantially in coming decade with lots more R&D
We’ll see. I won’t have long to wait
Private Ryan - funny you should mention the Lanarkshire WhatsApp issue, I’ve been researching it recently. This is the press release from the ICO last August:
https://ico.org.uk/about-the-ico/media-centre/news-and-blogs/2023/08/ico-reprimands-nhs-lanarkshire-for-sharing-patient-data-via-whatsapp/
And these were their recommendations to Lanarkshire. Note the first one in particular. There is only ONE company and one app I am aware of that can meet that recommendation to the letter ;)
Recommendations:
The ICO recommended that NHS Lanarkshire should take action to ensure their compliance with data protection law, including:
Consider implementing a secure clinical image transfer system, as part of NHS Lanarkshire’s exploration regarding the storage of images and videos within a care setting.
Before deploying new apps, consider the risks relating to personal data and include the requirement to assess and mitigate these risks in any approval process.
Ensure explicit communications, instructions or guidance are issued to employees on their data protection responsibilities when new apps are deployed.
Review all organisational policies and procedures relevant to this incident and amend where appropriate.
Ensure all staff are aware of their responsibilities to report personal data breaches internally without delay to the relevant team.
The ICO has asked NHS Lanarkshire to provide an update of actions taken within six months of the reprimand being issued.
The ICO has a revised approach to public sector enforcement, aiming to encourage greater data protection compliance from public authorities to prevent harms before they occur.